INOZYME PHARMA, INC. Deferred Tax Assets, Net

INOZYME PHARMA, INC. Deferred Tax Assets, Net

INOZYME PHARMA, INC. had Deferred Tax Assets, Net of $0 as of 2024-12-31, per its 10-K filed 2025-03-10.

Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net

us-gaap:DeferredTaxAssetsLiabilitiesNet · last filed 2025-03-10

• 2024-12-31: Deferred Tax Assets, Net $0.00.
• 2023-12-31: Deferred Tax Assets, Net $0.00.
• 2022-12-31: Deferred Tax Assets, Net $0.00.
• 2021-12-31: Deferred Tax Assets, Net $0.00.